DiaMedica Therapeutics Inc (DMAC) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
DiaMedica Therapeutics Inc. (DMAC)
Last diamedica therapeutics inc. earnings: 11/13 04:12 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Current Liabilities: $5.1 million as of December 31, 2025. Working Capital: $55.5 million as of December 31, 2025. Net Cash Used in Operating Activities: $29.1 million for the full year 2025. Research and Development Expenses: $24.6 million for the year ended December 31, 2025. General and Administrative Expenses: $9.8 million for the full year 2025. Warning! GuruFocus has detected 1 Warning Sign with DMAC. Is DMAC fairly valued? Test your thesis with our free DCF calculator. Release Date: March 31, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points DiaMedica Therapeutics Inc ( NASDAQ:DMAC ) reported significant progress in 2025, achieving key milestones across its pipeline. Positive interim results from the Phase 2 trial of DM199 in preeclampsia showed statistically significant reductions in blood pressure and uterine artery pulsatility index. DM199 demonstrated a favorable safety profile b
Show less
Read more
Impact Snapshot
Event Time:
DMAC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DMAC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DMAC alerts
High impacting DiaMedica Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
DMAC
News
- DiaMedica Therapeutics Highlights DM199 Preeclampsia Data, Stroke Interim Catalyst at RedChip Conference [Yahoo! Finance]Yahoo! Finance
- DiaMedica Therapeutics Inc. (DMAC) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- DiaMedica Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]Yahoo! Finance
- DiaMedica Therapeutics GAAP EPS of -$0.70 misses by $0.02 [Seeking Alpha]Seeking Alpha
DMAC
Earnings
- 3/30/26 - Miss
DMAC
Sec Filings
- 4/1/26 - Form ARS
- 4/1/26 - Form DEFA14A
- 4/1/26 - Form DEF
- DMAC's page on the SEC website